Tags

Type your tag names separated by a space and hit enter

Treating high blood pressure in diabetes: the evidence.
Semin Vasc Med 2002; 2(2):127-37SV

Abstract

Increases in blood pressure, even at modest levels, are associated with an increased risk of complications in diabetes. Trials have shown that treatment with blood pressure-lowering agents in type 2 diabetes lowers the risk of complications of cardiovascular and microvascular complications. ACE inhibitors appear superior in patients with microalbuminuria, although the choice of other agents is less clear, making blood pressure control itself more important than the particular agent used. The probability that a patient will require multiple therapies is increased in patients with diabetes, in part because of the increased likelihood of concurrent cardiovascular illness for which antihypertensives may have benefit. Finally, some drugs used to lower blood pressure have a benefit in individuals not considered hypertensive and appear to have a mechanism of action independent of blood pressure lowering.

Authors+Show Affiliations

Diabetes Trials Unit, Oxford University, Oxford, England. amanda.adler@dtu.ox.ac.uk

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

16222604

Citation

Adler, Amanda I.. "Treating High Blood Pressure in Diabetes: the Evidence." Seminars in Vascular Medicine, vol. 2, no. 2, 2002, pp. 127-37.
Adler AI. Treating high blood pressure in diabetes: the evidence. Semin Vasc Med. 2002;2(2):127-37.
Adler, A. I. (2002). Treating high blood pressure in diabetes: the evidence. Seminars in Vascular Medicine, 2(2), pp. 127-37.
Adler AI. Treating High Blood Pressure in Diabetes: the Evidence. Semin Vasc Med. 2002;2(2):127-37. PubMed PMID: 16222604.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Treating high blood pressure in diabetes: the evidence. A1 - Adler,Amanda I, PY - 2005/10/14/pubmed PY - 2005/11/9/medline PY - 2005/10/14/entrez SP - 127 EP - 37 JF - Seminars in vascular medicine JO - Semin Vasc Med VL - 2 IS - 2 N2 - Increases in blood pressure, even at modest levels, are associated with an increased risk of complications in diabetes. Trials have shown that treatment with blood pressure-lowering agents in type 2 diabetes lowers the risk of complications of cardiovascular and microvascular complications. ACE inhibitors appear superior in patients with microalbuminuria, although the choice of other agents is less clear, making blood pressure control itself more important than the particular agent used. The probability that a patient will require multiple therapies is increased in patients with diabetes, in part because of the increased likelihood of concurrent cardiovascular illness for which antihypertensives may have benefit. Finally, some drugs used to lower blood pressure have a benefit in individuals not considered hypertensive and appear to have a mechanism of action independent of blood pressure lowering. SN - 1528-9648 UR - https://www.unboundmedicine.com/medline/citation/16222604/Treating_high_blood_pressure_in_diabetes:_the_evidence_ L2 - http://www.diseaseinfosearch.org/result/2236 DB - PRIME DP - Unbound Medicine ER -